Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Background The combined post-operative use of diuretics and/or renin-angiotensin-aldosterone system (RAAS) inhibitors may increase the risk of nonsteroidal anti-inflammatory drug (NSAID) associated renal failure because of a drug–drug interaction. Objective The aim of this study was to investigate the effect of the short-term (<4 days) post-operative combined use of NSAIDs with diuretics and/or RAAS inhibitors on renal function and blood pressure. Setting One teaching hospital in the Netherlands. Method The study-design was a prospective, observational cohort-study. Based on postoperative treatment with NSAIDs, the intervention-group was compared to a control-group (no NSAIDs treatment). Main outcome measure Systolic blood pressure and renal function expressed by the estimated glomular filtration rate (eGFR) calculated with the modification of renal desease formula. Results 97 patients were included in the intervention-group, 53 patients in the control-group. Patient characteristics were comparable except for one variable: ‘combined use of a diuretic with a RAAS inhibitor’ which was higher in the control-group (62 vs. 43 %, p = 0.046). Odds ratio for clinically relevant increase in systolic blood pressure was 0.66 (CI95 % 0.3–1.5). Odds ratio for clinical relevant decrease in renal function was 2.44 (CI95 % 1.1–5.2). On day 4 eGFR of 3 patients in the intervention- and 1 in the control-group was <50 ml/min/1.73 m2. Conclusion Odds ratios showed no significant difference of a clinically relevant increase in systolic blood pressure but showed a higher risk for a clinically relevant decrease in renal function in the intervention group. However this decrease resulted in a relevant impaired renal function (<50 ml/min/1.73 m2) in only 3 patients in the interventiongroup and 1 patient in the control-group. In the post-operative patient, without preexisting impaired renal function, concurrent diuretics and/or renin-angiotensinaldosterone system inhibitor therapy can be combined with short-term NSAID treatment.
- Fijn, R, Koorevaar, RT, Brouwers, JRBJ (2003) Prevention of heterotopic ossification after total hip replacement with NSAIDs. Pharm World Sci 25: pp. 138-145 CrossRef
- Duyvendak M, van Roon EN, Naunton M, Bosman J, Klopotowska J, Brouwers JRBJ. Peri-operative drug management: clinical pharmacy services reduce potential drug related problems in orthopedic patients. Chapter 6 In: Pharmaceutical care by clinical pharmacists in patients with muskuloskeletal disease. Thesis Duyvendak M, Groningen, The Netherlands; 2010 p. 113–127. ISBN:978-90-367-4538-3.
- Aronson, JK (2010) Side effects of drugs annual 32. Elsevier, Amsterdam
- White, B (2007) Cardiovascular effects of the cyclooxygenase inhibitors. Hypertension 49: pp. 408-418 CrossRef
- Whelton, A, Schulman, G, Wallemark, C (2000) Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 160: pp. 1465-1470 CrossRef
- Loboz, KK, Shenfield, GM (2004) Drug combinations and impaired renal function—the ‘triple whammy’’. Br J Clin Pharmacol 59: pp. 239-243 CrossRef
- Heerdink, ER, Leufkens, HG, Herings, RM (1998) NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 158: pp. 1108-1112 CrossRef
- Scherning Olsen AM, Fosbol EL, Lindhardsen J, Folke F, Charlot M, Selmer C et al. Duration of treatment with NSAIDs drugs and impact on risk of death and recurrent myocardial infarction in patients with myocardial infarction: a nationwide cohort study. Circulation. 2011;123:2226–35.
- Note for guidance on the evaluation of the pharmacokinetics of medicinal product in patients with impaired renal function. 23 June 2004. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003123.pdf.
- Juhlin, T, Jonsson, BA, Hoglund, P (2008) Renal effects of aspirin are clearly dose-dependent and are of clinical importance from a dose of 160 mg. Eur J Heart Fail 10: pp. 892-898 CrossRef
- Meune, C, Mourad, JJ, Bergman, JF, Spaulding, C (2003) Interaction between cyclooxygenase and the rennin-angiotensin-aldosterone system: rationale and clinical relevance. J Renin Angiotensin Aldosterone Syst 4: pp. 149-154 CrossRef
- Traynor, J, Mactier, R, Geddes, CC, Fox, JG (2006) How to measure renal function in clinical practice. BMJ 333: pp. 733-737 CrossRef
- Morgan, TO, Anderson, A, Bertram, D (2000) Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. Am J of Hypertens 13: pp. 1161-1167 CrossRef
- Shlipak, MD, Sarnak, MJ, Katz, R (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352: pp. 2049-2060 CrossRef
- Groban, L, Butterworth, J (2006) Perioperative management of chronic heart failure. Anesth Analg 103: pp. 557-575 CrossRef
- Lee A, Cooper MC, Craig JC, Knight JF, Keneally JP. Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function (Review). Cochrane Libr. 2007;2:1–31.
- Bouvy, ML, Heerdink, ER, Hoes, AW, Leufkens, HG (2003) Effects of NSAIDs on the incidence of hospitalisations for renal dysfunction in users of ACE inhibitors. Drug Saf 26: pp. 983-989 CrossRef
- Levey, SA, Bosch, JP, Breyer Lewis, J (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130: pp. 461-470
- Rule, AD, Larson, TS, Bergstralh, EJ (2004) Using serum creatinine to estimate glomular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141: pp. 929-937
- Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function
International Journal of Clinical Pharmacy
Volume 34, Issue 3 , pp 468-474
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Blood pressure
- Drug interaction
- RAAS inhibitors
- Renal insufficiency
- Industry Sectors
- Author Affiliations
- 1. Department of Pharmacy, Diaconessen Hospital Meppel & Bethesda Hospital Hoogeveen, Hoogeveenseweg 38, Postbox 502, 7940 AM, Meppel, The Netherlands
- 2. Department of Clinical Pharmacy, Deventer Hospital, Deventer, The Netherlands
- 3. Department of Pharmacotherapy and Pharmaceutical Care, University Groningen, Groningen, The Netherlands
- 4. Department of Orthopaedics, Deventer Hospital, Deventer, The Netherlands